TNF and colorectal carcinoma: A previously published study reported the anti-tumor properties of a MIM employing LD and ULD of cytokines such as IFN-α and IL-2 in association with other actives, like tumor necrosis factor (TNF)-α at 5 CH, specifically in the context of colorectal cancer (CRC) [5].